Lyell Immunopharma, Inc. (LYEL) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time LYEL price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 51.9 Neutral
Market Cap $346.0M
Volume 82.5K
Fundamentals — 10-Q Q2 2026
Revenue $6,000
Net Income $-68.9M
EPS $-3.05
Operating Margin -1526633.3%
Net Margin -1148466.7%
P/E Ratio -4.6x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Bulis Veronica Sanchez | VP, Corporate Controller | Sell | 621 | $14.34 | $8,905 | 2026 Aug 10 |
| Lee Gary K. | Chief Scientific Officer | Sell | 131 | $14.34 | $1,879 | 2026 Aug 10 |
| Hill Stephen J. | Chief Operating Officer | Sell | 89 | $14.34 | $1,276 | 2026 Aug 10 |
| Seely Lynn | President and CEO | Sell | 390 | $14.34 | $5,593 | 2026 Aug 10 |
| Innovative Cellular Therapeutics Holdings Ltd | Insider | Sell | 10 | $13.70 | $137 | 2026 Jul 17 |
| Innovative Cellular Therapeutics Holdings Ltd | Insider | Sell | 10 | $13.73 | $137 | 2026 Jul 16 |
| Shook David | Chief Medical Officer | Sell | 1,977 | $12.64 | $24,989 | 2026 Jun 10 |
| Seely Lynn | President and CEO | Sell | 388 | $18.91 | $7,337 | 2026 May 11 |
| Lee Gary K. | Chief Scientific Officer | Sell | 130 | $18.92 | $2,460 | 2026 May 11 |
| Hill Stephen J. | Chief Operating Officer | Sell | 89 | $18.92 | $1,684 | 2026 May 11 |
| Bulis Veronica Sanchez | VP, Corporate Controller | Sell | 217 | $18.91 | $4,103 | 2026 May 11 |
| ARCH Venture Partners IX, LLC | 10% Owner | Buy | 488,090 | $25.61 | $12.5M | 2026 Mar 6 |
| ARCH Venture Fund XIII, L.P. | 10% Owner | Buy | 488,090 | $25.61 | $12.5M | 2026 Mar 6 |
| Hill Stephen J. | Chief Operating Officer | Sell | 95 | $16.12 | $1,531 | 2025 Nov 10 |
| Seely Lynn | President and CEO | Sell | 412 | $16.11 | $6,637 | 2025 Nov 10 |
| Lee Gary K. | Chief Scientific Officer | Sell | 138 | $16.16 | $2,230 | 2025 Nov 10 |
| Bulis Veronica Sanchez | VP, Corporate Controller | Sell | 239 | $16.10 | $3,848 | 2025 Nov 10 |
| Newton Charles W. | Chief Financial Officer | Sell | 1,453 | $10.54 | $15,315 | 2025 Aug 21 |
| Seely Lynn | President and CEO | Sell | 7,257 | $10.54 | $76,489 | 2025 Aug 21 |
| Hill Stephen J. | Chief Operating Officer | Sell | 1,004 | $10.54 | $10,582 | 2025 Aug 21 |
Take LYEL further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put LYEL in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Lyell Immunopharma, Inc. next reports.
Set alerts on LYEL
Get notified when Lyell Immunopharma, Inc. hits your price targets or technical conditions are met.
Get Started Free